CLOVER BIOPHARMACEUTICALS LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 2197 for the last semiannual is -10.94 M HKD, and it's 125.98% lower compared to the previous semiannual. The net income of H1 24 is -103.08 M HKD.